Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
162.00
-2.00 (-1.22%)
Nov 17, 2026, 1:59 PM CST

Lin BioScience Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
134,33032,84210,8128,94612,58312,832
Market Cap Growth
487.28%203.77%20.85%-28.90%-1.94%83.66%
Enterprise Value
132,79430,1558,4977,78811,31411,817
Last Close Price
166.5039.7013.6611.3217.0318.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
12.681.312.022.617.2528.33
P/TBV Ratio
12.823.093.954.4111.1828.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.030.01
Net Debt / Equity Ratio
-0.65-0.65-0.97-0.94-0.92-1.78
Net Debt / EBITDA Ratio
4.175.713.572.953.612.39
Net Debt / FCF Ratio
7.2111.235.053.174.172.76
Quick Ratio
37.5457.6833.6623.7020.601.72
Current Ratio
38.0858.1834.4524.6920.941.74
Return on Equity (ROE)
-21.83%-16.93%-28.66%-41.08%-41.98%-70.57%
Return on Assets (ROA)
-15.73%-11.54%-19.97%-25.16%-20.05%-19.74%
Return on Capital Employed (ROCE)
-15.50%-11.40%-27.10%-31.70%-25.10%-74.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.20%-4.15%-6.88%-7.68%-2.49%-3.39%
FCF Yield
-1.71%-4.41%-9.48%-11.34%-3.05%-2.27%
Buyback Yield / Dilution
-3.46%-4.46%-6.24%-3.14%-4.27%-10.73%